DrugPatentWatch Database Preview
Drugs in Development Information for GDC-0152
Summary for GDC-0152
| US Patents | 7 |
| International Patents | 106 |
| US Patent Applications | 10 |
| WIPO Patent Applications | 0 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 3 (2010-07-01) |
| Vendors | 16 |
US Patents for GDC-0152
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| GDC-0152 | ➤ Sign Up | Inhibitors of IAP | Genentech, Inc. (South San Francisco, CA) | ➤ Sign Up |
| GDC-0152 | ➤ Sign Up | Inhibitors of IAP | Genentech, Inc. (South San Francisco, CA) | ➤ Sign Up |
| GDC-0152 | ➤ Sign Up | Inhibitors of IAP | Genentech, Inc. (South San Francisco, CA) | ➤ Sign Up |
| GDC-0152 | ➤ Sign Up | Inhibitors of IAP | Genentech, Inc. (South San Francisco, CA) | ➤ Sign Up |
| GDC-0152 | ➤ Sign Up | Inhibitors of IAP | GENENTECH, INC. (South San Francisco, CA) | ➤ Sign Up |
| GDC-0152 | ➤ Sign Up | Biomarkers for IAP inhibitor therapy | Novartis AG (Basel, CH) | ➤ Sign Up |
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
International Patents for GDC-0152
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| GDC-0152 | Australia | 2005270104 | 2024-07-02 | ➤ Sign Up |
| GDC-0152 | Australia | 2009243421 | 2024-07-02 | ➤ Sign Up |
| GDC-0152 | Australia | 2011236020 | 2024-07-02 | ➤ Sign Up |
| GDC-0152 | Australia | 2012241077 | 2024-07-02 | ➤ Sign Up |
| GDC-0152 | Brazil | PI0511350 | 2024-07-02 | ➤ Sign Up |
| GDC-0152 | Canada | 2570321 | 2024-07-02 | ➤ Sign Up |
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
